Vancouver-based Molecular Testing Labs appoints Eric Strafel as its new CEO, according to a news release.
Strafel said in an email that he is remaining in Dallas with frequent travel to the lab in Vancouver and the company’s other field locations around the country.
“It’s critical to keep open lines of communication with employees, so I’ll be doing round table discussions with everyone in the company over the next couple months to onboard, then maintaining frequent touch points from there,” he said.
Strafel joins the company with over 25 years of experience as a leader in enterprise businesses.
“Molecular Testing Labs is one of the most innovative health science companies in the industry, and I’m proud to join their leadership team as CEO,” Strafel said in the release. “The future of healthcare is rooted in expanding access to care. Molecular’s proprietary self-collection solutions coupled with clinical processing and digital framework are key to securing quality, affordable healthcare for all communities who have limited access to testing and treatment.”
Before joining Molecular Testing Labs, Strafel served as president and CEO of Dallas-based Aviall. According to the release, his time at Aviall resulted in three consecutive years of 20% growth and growing annual revenues to more than $5 billion.
“Molecular Testing Labs was founded on principles of equity in care. Our model is to identify and address barriers in testing and clinical processing that lead to poor health outcomes and address those with innovation. I can think of no one better than Eric Strafel to lead Molecular Testing Labs,” Adam Blackwell, co-founder of Molecular Testing Labs, said in the release. “Eric’s vision and track record of growing businesses exactly like ours and his long history in economic justice and equity work make him a perfect fit for Molecular, and we are lucky to have him.”
Strafel also is the founder of Dallas-based SUMMi7, a business consulting agency.
